Bosh sahifa4568 • TYO
add
Daiichi Sankyo Co Ltd
Yopilish kursi
4 483,00 ¥
Kunlik diapazon
4 433,00 ¥ - 4 501,00 ¥
Yillik diapazon
3 805,00 ¥ - 6 257,00 ¥
Bozor kapitalizatsiyasi
8,64 trln JPY
Oʻrtacha hajm
5,09 mln
Narx/foyda
33,89
Dividend daromadliligi
1,35%
Asosiy maydon
TYO
Bozor yangiliklari
GS
1,12%
0,35%
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
(JPY) | sen, 2024info | Y/Y qiyosi |
---|---|---|
Daromad | 446,55 mlrd | 18,92% |
Joriy xarajat | 254,60 mlrd | 10,82% |
Sof foyda | 61,29 mlrd | 53,26% |
Sof foyda marjasi | 13,73 | 28,92% |
Har bir ulushga tushum | — | — |
EBITDA | 110,60 mlrd | 69,06% |
Amaldagi soliq stavkasi | 25,60% | — |
Balans
Jami aktivlari
Jami passivlari
(JPY) | sen, 2024info | Y/Y qiyosi |
---|---|---|
Naqd pul va qisqa investitsiyalar | 707,67 mlrd | 19,79% |
Jami aktivlari | 3,30 trln | 24,46% |
Jami passivlari | 1,67 trln | 58,69% |
Umumiy kapital | 1,62 trln | — |
Tarqatilgan aksiyalar | 1,90 mlrd | — |
Narxi/balansdagi bahosi | 5,24 | — |
Aktivlardan daromad | 6,97% | — |
Kapitaldan daromad | 13,24% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
(JPY) | sen, 2024info | Y/Y qiyosi |
---|---|---|
Sof foyda | 61,29 mlrd | 53,26% |
Operatsiyalardan naqd pul | 33,49 mlrd | 284,55% |
Sarmoyadan naqd pul | -10,87 mlrd | -108,72% |
Moliyadan naqd pul | -78,62 mlrd | -75,67% |
Naqd pulning sof oʻzgarishi | -97,59 mlrd | -237,26% |
Boʻsh pul | 53,27 mlrd | -46,31% |
Haqida
Daiichi Sankyo Company, Limited is a global pharmaceutical company and the second-largest pharmaceutical company in Japan. It achieved JPY 1,278 billion in revenue in 2022. The company owns the American pharmaceutical company American Regent.
Daiichi Sankyo, Inc. began operating in the U.S. in 2006. It is the U.S. subsidiary of Daiichi Sankyo Company, Limited, and a member of the Daiichi Sankyo Group. The organization, which includes U.S. commercial operations and global clinical development, is headquartered in Basking Ridge, New Jersey.
Daiichi Sankyo Europe, GmbH, the European subsidiary, is headquartered in Munich, Germany. The organization is responsible for development and manufacturing for 12 European countries.
Daiichi Sankyo Company, Limited is a full member of the European Federation of Pharmaceutical Industries and Associations and of the International Federation of Pharmaceutical Manufacturers and Associations. Wikipedia
CEO
Tashkil etilgan
28-sen, 2005
Bosh ofis
Xodimlar soni
18 726